Literature DB >> 26606510

Novel Nonsense Mutation in the NLRP7 Gene Associated with Recurrent Hydatidiform Mole.

Yuki Ito1, Kayoko Maehara, Eisuke Kaneki, Kentaro Matsuoka, Naoko Sugahara, Tomoko Miyata, Hiromi Kamura, Yuko Yamaguchi, Ayako Kono, Kazuhiko Nakabayashi, Ohsuke Migita, Ken Higashimoto, Hidenobu Soejima, Aikou Okamoto, Hitomi Nakamura, Tadashi Kimura, Norio Wake, Takeshi Taniguchi, Kenichiro Hata.   

Abstract

AIM: This study aimed to clarify the genetic and epigenetic features of recurrent hydatidiform mole (RHM) in Japanese patients.
METHODS: Four Japanese isolated RHM cases were analyzed using whole-exome sequencing. Villi from RHMs were collected by laser microdissection for genotyping and DNA methylation assay of differentially methylated regions (DMRs). Single nucleotide polymorphisms of PEG3 and H19 DMRs were used to confirm the parental origin of the variants.
RESULTS: A novel homozygous nonsense mutation in NLRP7 (c.584G>A; p.W195X) was identified in 1 patient. Genotyping of one of her molar tissue revealed that it was biparental but not androgenetic in origin. Despite the fact that the RHM is biparental, maternally methylated DMRs of PEG3, SNRPN and PEG10 showed complete loss of DNA methylation. A paternally methylated DMR of H19 retained normal methylation.
CONCLUSIONS: This is the first Japanese case of RHM with a novel homozygous nonsense NLRP7 mutation and a specific loss of maternal DNA methylation of DMRs. Notably, the mutation was identified in an isolated case of an ethnic background that has not previously been studied in this context. Our data underscore the involvement of NLRP7 in RHM pathophysiology and confirm that DNA methylation of specific regions is critical.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26606510     DOI: 10.1159/000441780

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  5 in total

1.  Maternal heterozygous NLRP7 variant results in recurrent reproductive failure and imprinting disturbances in the offspring.

Authors:  Lukas Soellner; Matthias Begemann; Franziska Degenhardt; Annegret Geipel; Thomas Eggermann; Elisabeth Mangold
Journal:  Eur J Hum Genet       Date:  2017-05-31       Impact factor: 4.246

Review 2.  NLRP7: From inflammasome regulation to human disease.

Authors:  Jessica Carriere; Andrea Dorfleutner; Christian Stehlik
Journal:  Immunology       Date:  2021-06-30       Impact factor: 7.215

3.  NLRP7 contributes to in vitro decidualization of endometrial stromal cells.

Authors:  Jyun-Yuan Huang; Pei-Hsiu Yu; Yueh-Chun Li; Pao-Lin Kuo
Journal:  Reprod Biol Endocrinol       Date:  2017-08-15       Impact factor: 5.211

4.  Pathogenic variant in NLRP7 (19q13.42) associated with recurrent gestational trophoblastic disease: Data from early embryo development observed during in vitro fertilization.

Authors:  E Scott Sills; Alexandra J Obregon-Tito; Harry Gao; Thomas K McWilliams; Anthony T Gordon; Catharine A Adams; Rima Slim
Journal:  Clin Exp Reprod Med       Date:  2017-03-31

5.  NLRP7 is expressed in the ovine ovary and associated with in vitro pre-implantation embryo development.

Authors:  Guangdong Li; Xiuzhi Tian; Dongying Lv; Lu Zhang; Zhenzhen Zhang; Jing Wang; Minghui Yang; Jingli Tao; Teng Ma; Hao Wu; Pengyun Ji; Yingjie Wu; Zhengxing Lian; Wei Cui; Guoshi Liu
Journal:  Reproduction       Date:  2019-11       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.